As with many wild and dramatic stories, the story of Theranos and its former CEO Elizabeth Holmes is adapted several times. The Bad Blood spearheaded by Jennifer Lawrence, that was just caught by Apple, will likely get the most attention. (Expect it to get a lot of Oscar love, like Adam McKay’s recent films, Vice, and The Big Short.) But don’t count Hulu’s miniseries The Dropout. First announced in 2019 With Kate McKinnon as the infamous serial fibber Elizabeth Holmes, the series will now star Amanda Seyfried when it premieres on March 3, 2022.
Judging by the first round of pictures, Seyfried captures the attraction of Holmes with big eyes. It’s also surprising to see the great Naveen Andrews (Lost, Sense8) as Ramesh “Sunny” Balwani, Theranos ‘former COO and Holmes’ former boyfriend. According to Hulu, the series will “follow an incredible story of ambition and fame that went horribly wrong. How did the world’s youngest self-made billionaire lose it all in the blink of an eye?”
Theranos managed to raise over $ 700 million from investors due to its seemingly miraculous device, the Edison. It was a blood testing machine that was designed to test for a variety of diseases. But of course it was all a lie. Coverage from the Wall Street Journal and others revealed that the company’s technology never really worked. Ultimately it is The SEC accused Theranos, Holmes and Balwani of “massive fraud”.
Alex Gibneys HBO documentary, The Inventor, did a good job covering the drama surrounding Theranos and Holmes’ unusual mystique. But there is also a lot to do in a dramatic adaptation.
All products recommended by Engadget are selected by our editorial team independently of our parent company. Some of our stories contain affiliate links. If you buy something through one of these links, we may earn an affiliate commission.